The role of sex genotype in paediatric CNS tumour incidence and survival.

Soon, Wai Cheong, Goacher, Edward, Solanki, Sandeep, Hayes, Josie, Kapetanstrataki, Melpo, Picton, Susan, Chumas, Paul Dominic and Mathew, Ryan Koshy (2021) The role of sex genotype in paediatric CNS tumour incidence and survival. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. ISSN 1433-0350.

Full text not available from this repository.
Official URL:



Evidence exists, in CNS germinomas and medulloblastomas (MB), that patient sex significantly influences incidence and outcome. The role of sex genotype in other paediatric CNS tumours remains unclear. This study sought to examine the role of sex genotype in CNS tumour incidence and overall survival (OS).


Age-adjusted incidence and OS rates were collected from the Surveillance Epidemiology and End Result (SEER) registry between 2000 and 2011 for common paediatric (<=19 years) CNS tumours: pilocytic astrocytoma (PA), anaplastic astrocytoma, glioblastoma (GBM), medulloblastoma, supratentorial CNS embryonal tumour, ependymoma, and germinoma. All patients with histologically confirmed, ICD-03 coded, first tumours, were included. Kaplan-Meier and Cox regression analyses were used to calculate hazard ratios (HR).


The total cases are as follows: males=3018 and females=2276. Highest incidence was seen in PA (n=2103). GBM displayed the worst OS, whilst PA displayed the best. Higher incidence was observed in males for all tumours, except PA. Females with ependymoma had significantly better OS compared to males, whereas males with germinomas had better OS compared to females. Females <1 year with AA had better OS than males. Increasing age significantly improved male and female survival in ependymoma and medulloblastoma.


Interrogating population-based registries such as SEER minimises bias and provides credible data. Observed differences in incidence and OS between the sexes for different paediatric CNS tumours provide useful prognostic information for clinicians. Sex genotype was a significant independent prognostic factor in ependymomas and germinomas. Further investigation of possible epigenetic and hormonal differences may provide sex-specific vulnerabilities that may be exploitable for targeted therapy.

Item Type: Article
Subjects: QZ Pathology. Oncology
WS Paediatrics. Child health
Divisions: Womens and Childrens > Paediatrics
Related URLs:
Depositing User: Miss Emily Johnson
Date Deposited: 10 May 2021 13:43
Last Modified: 10 May 2021 13:43

Actions (login required)

View Item View Item